Guerbet SA (GBT) – Company Profile and SWOT Analysis

Guerbet SA (GBT) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Guerbet SA (Guerbet) is a manufacturer of contrast agents. The company provides a wide range of imaging products, solutions, and services for Computed Tomography (CT)/Cath Lab examinations, magnetic resonance imaging (MRI), and interventional imaging. CT/Cath Lab contrast agents consist of iodinated active ingredients and few examinations of the digestive tract use barium-based products. MRI imaging uses gadolinium complexes. Guerbet has a presence in Europe, Asia, and North and South America. The company offers products directly through its sales structure, distributors, and license holders. Guerbet is headquartered in Villepinte, France.

Scope

• Detailed information on Guerbet SA required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Guerbet SA in the form of a SWOT analysis

• An in-depth view of the business model of Guerbet SA including a breakdown and examination of key business segments

• News about Guerbet SA, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Guerbet SA and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Guerbet SA as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Guerbet SAs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Merit Medical Systems Inc

GE HealthCare Technologies Inc

ulrich GmbH & Co KG

Boston Scientific Corp

SuperSonic Imagine SA

Nemoto Kyorindo Co Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Guerbet SA - Key Facts

Guerbet SA - Key Employees

Guerbet SA - Key Employee Biographies

Guerbet SA - Major Products and Services

Guerbet SA - History

Guerbet SA - Company Statement

Guerbet SA - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Guerbet SA - Business Description

Product Category: Diagnostic Imaging

Overview

Performance

Product Category: Interventional Imaging

Overview

Performance

Geographical Segment: European Markets

Performance

Geographical Segment: Other Markets

Performance

R&D Overview

Guerbet SA - Corporate Strategy

Guerbet SA - SWOT Analysis

SWOT Analysis - Overview

Guerbet SA - Strengths

Guerbet SA - Weaknesses

Guerbet SA - Opportunities

Guerbet SA - Threats

Guerbet SA - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Guerbet SA, Medical Equipment, Deals By Year, 2018 to YTD 2024

Guerbet SA, Medical Equipment, Deals By Type, 2018 to YTD 2024

Guerbet SA, Recent Deals Summary

Section 5 – Company’s Recent Developments

Jul 25, 2024: Guerbet Publishes Revenue for H1 2024

May 22, 2024: NUCLIDIUM and Guerbet Form Strategic Partnership to Support the Advancement of targeted Copper-based Radiotheranostics

Mar 20, 2024: Guerbet Announces 2023 Full-Year Results

Mar 20, 2024: Guerbet: Change in Guerbet’s Board of Directors.

Mar 11, 2024: Guerbet strengthens its Executive Committee with two new appointments to consolidate its medium and long-term ambitions.

Sep 20, 2023: Guerbet: 2023 half-year results

Jul 17, 2023: Guerbet wins PI-CAI Grand Challenge on detection of prostate cancer

Jul 10, 2023: Guerbet Strengthens Its Executive Committee With Two New Appointments to Accelerate Its Commercial and Industrial Development

Mar 22, 2023: Guerbet Announces 2022 annual results

Mar 22, 2023: Guerbet: 2022 annual results

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Guerbet SA, Key Facts

Guerbet SA, Key Employees

Guerbet SA, Key Employee Biographies

Guerbet SA, Major Products and Services

Guerbet SA, History

Guerbet SA, Other Locations

Guerbet SA, Subsidiaries

Guerbet SA, Key Competitors

Guerbet SA, Ratios based on current share price

Guerbet SA, Annual Ratios

Guerbet SA, Annual Ratios (Cont…1)

Guerbet SA, Annual Ratios (Cont…2)

Guerbet SA, Interim Ratios

Guerbet SA, Medical Equipment, Deals By Year, 2018 to YTD 2024

Guerbet SA, Medical Equipment, Deals By Type, 2018 to YTD 2024

Guerbet SA, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Guerbet SA, Performance Chart (2019 – 2023)

Guerbet SA, Ratio Charts

Guerbet SA, Medical Equipment, Deals By Year, 2018 to YTD 2024

Guerbet SA, Medical Equipment, Deals by Type, 2018 to YTD 2024

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports